Drug product
Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
D-1412-2012
Product summary
- Event
- Event 62392
- Status
- Terminated
- Classification
- Class II
- Quantity
- 14,465 bottles
- Official record key
drug-enforcement:D-1412-2012
Official wording
Reason: Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.
Code information: Lot #0ZP5128 exp; 8/2013
Distribution pattern: Nationwide
Derived failure modes
-
Foreign material or chemical contamination
Foreign Tablets